Moss Adams Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Moss Adams Wealth Advisors's PFE Position: Q2 2026 in Review
Moss Adams Wealth Advisors reduced its Pfizer (PFE) stake by 8.5% in Q2 2026, selling an estimated $69.5K and leaving 28,570 shares worth $688K. The position accounts for 0.04% of the portfolio, ranked #123.
Moss Adams Wealth Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $877K in Q1 2026. 1,197 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Moss Adams Wealth Advisors held 28,570 shares of Pfizer worth $688K as of Q2 2026.
- Moss Adams Wealth Advisors sold 2,658 Pfizer shares in Q2 2026, an estimated $69.5K.
- Pfizer made up 0.04% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #123 holding.
- Moss Adams Wealth Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Moss Adams Wealth Advisors's Pfizer position peaked at $877K in Q1 2026.
- 1,197 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.